Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. - Wikidata - wikimedia - TriplyDB

Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

http://www.wikidata.org/entity/Q34121237

about

Adjuvant therapy for resected pancreatic cancer Chinese herbal medicine for advanced pancreatic cancer Perspectives in the treatment of pancreatic adenocarcinoma Non-invasive diagnosis of focal liver lesions: an individualized approach CIP2A down regulation enhances the sensitivity of pancreatic cancer cells to gemcitabine.The role of the GP in follow-up cancer care: a systematic literature review.A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen).A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative netw Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.Potential effects of Mina53 on tumor growth in human pancreatic cancer Intensity of follow-up after pancreatic cancer resection Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe: a randomized controlled trial.Clinical evaluation, imaging studies, indications for cytologic study and preprocedural requirements for duct brushing studies and pancreatic fine-needle aspiration: The Papanicolaou Society of Cytopathology Guidelines.Cutaneous metastasis from pancreatic cancer: A case report and systematic review of the literature.Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer.A qualitative study of patient and clinician attitudes regarding surveillance after a resection of pancreatic and peri-ampullary cancer.Elastography in pancreatic solid tumours diagnoses.Critical appraisal of clinical practice guidelines for treating pancreatic cancer based on the global disease burden.Route of gastroenteric reconstruction in pancreatoduodenectomy and delayed gastric emptying.Conditional survival of pancreatic ductal adenocarcinoma in surgical and nonsurgical patients: a retrospective analysis report from a single institution in China Soft-tissue metastasis revealing a pancreatic adenocarcinoma: one case report and a review of literature Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy.Quality appraisal of clinical practice guidelines on pancreatic cancer: a PRISMA-compliant article.Salvage pancreaticoduodenectomy after complete response to chemoradiotherapy for a previously unresectable pancreatic adenosquamous carcinoma: a case report.Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review ALDH1 might influence the metastatic capability of HeLa cells.MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.Tolerance and efficacy of palliative radiotherapy for advanced pancreatic cancer: A retrospective analysis of single-institutional experiences.Diagnostic management of pancreatic cancer.MGDG extracted from spinach enhances the cytotoxicity of radiation in pancreatic cancer cells.Mechanistic insights into self-reinforcing processes driving abnormal histogenesis during the development of pancreatic cancer Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-κB signaling pathway Neoadjuvant therapy in patients with pancreatic cancer: a disappointing therapeutic approach?Outcome quality standards in pancreatic oncologic surgery.Clinical evaluation, imaging studies, indications for cytologic study, and preprocedural requirements for duct brushing studies and pancreatic FNA: the Papanicolaou Society of Cytopathology recommendations for pancreatic and biliary cytology.miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients.Doppler tissue perfusion parameters in recognizing pancreatic malignant tumors.Adjuvant treatment for pancreatic ductal carcinoma.Role of taxanes in pancreatic cancer.

P2860

Q24186323-F237E9F8-AEE1-4D1C-8628-C65EB0E60521 Q24198080-C7806B7D-561E-4F59-B1A4-121348FD5DAF Q26797248-CE72B02B-158E-4340-A756-DA3DDE0E54E9 Q26999766-F0E70AC8-2943-4B78-BCFC-C4678FACCA2E Q27853345-CD8BFE55-12EA-4B23-A2D5-7F27EA6FF562 Q30241957-4AA7A131-8BE9-44A5-962A-2A7259340B61 Q33395577-5EBC9E1B-B311-4EDA-BC07-23299539BD7D Q33401811-98813CC0-39F0-42A8-9E6C-22F77A3B91C5 Q33457034-F836BD4E-3D7C-4AAB-B4AE-2657890074A5 Q33665450-CFB8AE90-36F4-4418-AC4B-0F33DEA539A0 Q33755366-0F39CBD9-6546-4794-B3BC-F697130A07A6 Q33791048-49B0F23E-C192-4289-A0F0-AD7B9A532A34 Q34112545-0C40F4D3-C292-4705-A933-1733C47121F0 Q34127295-0D2240BE-6C4C-42D4-9B35-826EAB808D1A Q34427404-67F77CA1-F971-4132-974A-71F8B65CE8BD Q35048269-D75EF196-A642-439A-BB1F-093FF6C94E91 Q35469061-ED5A4A2D-9E24-42FE-9228-FBE4D03E2CB6 Q35543615-061E8586-335D-4029-B739-743DDD9EE665 Q35543904-0C33BA0C-32FC-415B-8D41-8D28235D355D Q35658022-4DD5D250-0544-4DE5-ABD7-8018F2925773 Q35737695-ED3469F5-99F1-494D-B0A2-48BECD8112E2 Q35885413-931FF897-B3A3-4439-B719-04CF2AB57041 Q35890548-1BAF6B5B-7DF7-4CF9-9C0A-15A705B2E95F Q36009104-3D6F339A-6D20-4194-AEE4-F530BE9E2732 Q36152448-9FD26137-9131-4C28-8184-73683CB6B32B Q36159880-2406001B-75CD-42E3-9AB3-79CC6E18D3FC Q36278116-04AE66BD-CD4B-4C85-A702-6C46BAF5E373 Q36545809-A3CFBB31-AA99-4D4E-AAC6-9C01E9A3BE6F Q36953599-DECA5BCB-DAF2-4612-91FD-8A8E31B339D1 Q37129792-00544987-252E-4198-B481-58B4D2A13185 Q37431673-218B9779-53B2-43F9-B2CA-F3951BE78322 Q37671861-3273FDE7-6377-463B-B4A0-51F4AF8A9651 Q37697856-8C4D6804-EAB1-4761-86C0-D0641C641942 Q38161359-D56ED211-8230-4A95-9F5E-C8152F4BF727 Q38175881-7356D1AC-25AF-49D8-924F-465AC2CC8190 Q38189751-73D19D28-7254-41EE-A70A-74CFB7ABFB68 Q38888599-2CB3DDE5-E2D1-4AC5-B917-57C9D1A07300 Q39182171-516854D8-1B68-496B-A964-92690EF74DE5 Q39389872-D245AAC6-6D0A-4EF5-9DBA-B543379E973F Q42323567-4F22CCA7-D9C8-4574-9532-D5D643874CD1

P2860

Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

http://www.wikidata.org/entity/Q34121237

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Pancreatic cancer: ESMO Clinic ...... osis, treatment and follow-up.

@ast

Pancreatic cancer: ESMO Clinic ...... osis, treatment and follow-up.

@en

Pancreatic cancer: ESMO Clinic ...... osis, treatment and follow-up.

@nl

type

label

Pancreatic cancer: ESMO Clinic ...... osis, treatment and follow-up.

@ast

Pancreatic cancer: ESMO Clinic ...... osis, treatment and follow-up.

@en

Pancreatic cancer: ESMO Clinic ...... osis, treatment and follow-up.

@nl

prefLabel

Pancreatic cancer: ESMO Clinic ...... osis, treatment and follow-up.

@ast

Pancreatic cancer: ESMO Clinic ...... osis, treatment and follow-up.

@en

Pancreatic cancer: ESMO Clinic ...... osis, treatment and follow-up.

@nl

P1433

Q34121237-2E2D30B7-D029-4035-BBCC-DC751814F102

P1476

Q34121237-3A5163BE-E9BF-424A-8432-46E16844B0DF

P2093

Q34121237-5EE8FD07-5322-4773-92E8-BA71C047B025

Q34121237-B000E597-C986-43D3-83F2-B85E5966792F

P2860

Q34121237-001EB44C-BF04-487F-83EE-B11DD3DD6C4F

Q34121237-09A8D850-BBA1-4883-B047-D8F2F3FC7B2D

Q34121237-25900EE3-6B02-4645-AFC1-D92C0077005C

Q34121237-32EFF8CD-7CC8-4E34-AA6A-3CC87398DD09

Q34121237-425CA93C-4524-452A-AC03-DAFF929488C8

Q34121237-5AB42DDF-1B18-427D-A4F4-B63FB6140E47

Q34121237-635E4E08-459D-4339-8B49-106B62B85D33

Q34121237-6BE56BB9-5278-4058-AE66-5A8C19A2CC56

Q34121237-751E886E-FF0E-4E86-84C7-7320DFED1064

Q34121237-7C4AE7C3-6495-494A-B27B-8F88B0B2C764

P304

Q34121237-959F8C21-875B-4A27-BD07-35E662DE1288

P31

Q34121237-E756B6E5-9DCD-4BB5-8893-102514C7F61D

P356

Q34121237-FA63805F-043B-4B99-AA4D-71DE7B51772F

P478

Q34121237-68C91A58-83D7-42BB-9E80-411F7F969F02

P50

Q34121237-B33D4A5D-5BF2-471D-9D8B-4FE4E056000A

Q34121237-BF8A8693-EB4E-4B9A-A827-C936D31F9E3C

Q34121237-E86B4CB0-8F5C-41D0-BB4C-78D1CF9131F1

P577

Q34121237-4CBC951B-A197-48D2-AA93-91F13BBF47DC

P5875

Q34121237-233D90D3-434A-4863-B861-AC18159BF372

P698

Q34121237-773D2011-07AB-4369-9ACC-5C82CC66803F

P356

P1433

Annals of Oncology

P1476

Pancreatic cancer: ESMO Clinic ...... nosis, treatment and follow-up

@en

P2093

ESMO Guidelines Working Group

http://www.w3.org/2001/XMLSchema#string

S Jelic

http://www.w3.org/2001/XMLSchema#string

P2860

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

Estimates of the cancer incidence and mortality in Europe in 2006.

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Advances in counselling and surveillance of patients at risk for pancreatic cancer.

Is adjuvant 5-FU-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question.

Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.

Update on 3D and multiplanar MDCT in the assessment of biliary and pancreatic pathology.

Screening and surveillance approaches in familial pancreatic cancer.

P304

v55-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDQ165

http://www.w3.org/2001/XMLSchema#string

P478

21 Suppl 5

http://www.w3.org/2001/XMLSchema#string

P50

Massimo Falconi

Stefano Cascinu

Vincenzo Valentini

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51443587

http://www.w3.org/2001/XMLSchema#string

P698

20555103

http://www.w3.org/2001/XMLSchema#string